Boutique biotech IR Small independent firm with 2-10 employees presents a niche, high-touch investor relations offering. Opportunity to position as an outsourced IR partner for early-stage biotech companies seeking credibility and senior-level expertise.

Industry credibility Founders are former biotech senior executives with deep R&D, BD, finance, and IR experience. Leverage this credibility to pitch as a strategic advisor to biotech firms aiming to translate science value into investor value.

Value-focused messaging Emphasize understanding of science and value creation to investors. Potential sales angle: tailor IR programs that convert complex biotech narratives into clear funding and partnership opportunities.

Competitive positioning Competes with mid-sized IR firms by offering bespoke, senior-level guidance at a lean cost structure. Upsell opportunities with flexible service tiers for growing biotech companies nearing funding milestones.

Digital readiness Tech stack signals modern, web-enabled IR services with emphasis on performance and security (HTTP/3, HSTS). Potential cross-sell to biotech clients seeking robust, scalable IR platforms and cyber-secure investor communications.